Stem cell transplants into damaged myocardium may have the potential to improve cardiac function. We investigated the safety of transplanting unmanipulated autologous bone marrow into infarcted myocardium of patients undergoing coronary bypass surgery and assessed its efficacy to improve cardiac function. Fourteen patients with one or more areas of transmural myocardial infarction were studied. Autologous bone marrow was obtained by sternal bone aspirate at the time of surgery, diluted in autologous serum at a ratio of 1:2, and then injected 1 cm apart into the mid-depth of the left ventricular scar. There were no deaths, no perioperative myocardial infarctions, and no significant ventricular arrhythmias. Dobutamine stress echocardiography demonstrated overall improvement in the global and regional left ventricular function 6 weeks and 10 months after surgery. Of 34 infarcted left ventricular segments, 11 were injected with bone marrow alone, 13 were revascularized with a bypass graft alone, and 10 received bone marrow transplantation and a bypass graft in combination. Only the left ventricle segmental wall motion score of the areas injected with bone marrow and receiving a bypass graft in combination improved at low dose and at peak dobutamine stress. These findings suggest that transplantation of unmanipulated autologous bone marrow into scar tissue of the human heart is safe and enhances cardiac function only when used in combination with myocardial revascularization. This benefit can be seen after 6 weeks of the bone marrow transplant and is maintained after 10 months of follow-up.
INTRODUCTION
models of heart failure that a diverse range of cell types such as skeletal myoblasts (25) , bone marrow (15) , fetal Damage to the heart muscle following myocardial and neonatal cardiomyocytes (14, 22) , and even autoloinfarction results in fibrous scarring of the ventricles, gous heart cells (9) can improve cardiac function. Recentremodeling and expansion of the infarct zone, and imly, it has been reported that the intramuscular injection pairment of pump function. The resultant contractile inof autologous myoblasts in a patient with heart failure efficiency can lead to congestive heart failure, a condiresulted in significant improvement of cardiac function tion with a prevalence of 3.9% in the general population (11) . The use of the patient's own cells for the regenera- (13) and an annual mortality of greater than 10% (5).
tion of cardiac muscle has the advantages that it is ethi-Despite advances in treatment, the management of the cally acceptable and immunosuppression is unnecessary. patient with end-stage heart failure is difficult. Heart
The use of bone marrow cells as opposed to myoblasts and transplantation is restricted by shortage of donors, proother cell types has the additional benefit of ready availcedures of cardiomyoplasty and surgical remodeling of ability, without the need for in vitro cell culture preparathe heart are unproven, and the concepts of the total artition. ficial heart or porcine xenograft transplantation remain This nonrandomized study was designed to investiexperimental. An alternative strategy involves the transgate the safety and potential efficacy of the intramyocarplantation of cell lines that can differentiate into muscle dial injection of unmanipulated autologous bone marrow to restore function or prevent remodeling in the infarcted cells into the scarred myocardium of patients undergoing heart. In this regard, it has been demonstrated in animal coronary bypass surgery. 8 GALIÑ ANES ET AL.
MATERIALS AND METHODS
addition the anteroapical area was injected in two of the patients.
Patients and Selection Criterion

Assessment of Perioperative Myocardial Injury
Ethical approval for this study was obtained from the Leicestershire Health Ethics Committee. Fourteen patients Following surgery all patients were admitted to the with a Canadian Cardiovascular Society score for angina cardiac intensive care unit and the heart rhythm was monof ≥2 referred for coronary artery surgery consented to itored for the first 24 h postoperatively with a 12-lead enter the study. Selection criteria included a history of ECG performed at 6 and 24 h following surgery. Creone or more myocardial infarctions and the presence of atine kinase and troponin T were also measured at 6 and one or more areas of severe myocardial contractile ab-24 h postoperatively using standard assays. normality (akinesis or dyskinesis) with no contractile Follow-up improvement during low dobutamine stress. This stress
The patients were reviewed at 6 weeks and 10 months echocardiographic definition of myocardial infarction postoperatively and questioned regarding angina status was confirmed by the presence of fibrosis on the surface and postoperative course. of the heart during surgery. All the scarred areas in the left ventricle free wall, but not those in the intraventricu-Dobutamine Stress Echocardiography (DSE) lar septum, were injected with bone marrow cells. Coro-DSE was performed on all patients prior to surgery nary artery vessels with a stenotic lesion of ≥50% on the and at 6 weeks and 10 months following surgery. Calangiogram were revascularized with a bypass graft; only cium antagonists and β-adrenoceptor antagonists were those vessels exhibiting a small caliber (e.g., <1 mm in discontinued 48 h before DSE. Images were acquired at diameter) were considered ungraftable. All 14 patients baseline and during infusion of dobutamine at low dose included in the study received coronary artery bypass (10 µg/kg/min) and peak stress (maximum dobutamine grafts as well as autologous bone marrow transplantadose of 40 µg/kg/min). tion. None of the patients had percutaneous angioplasty Digitized images were analyzed by two independent at any time prior to or after surgery. assessors (D.T.C., J.E.D.) who were blinded to the coronary anatomy and the treatment. Using the 16-segment Procurement of Bone Marrow and Transplantation model of the left ventricle, the left ventricular wall mo-Venous blood (20 ml) was taken from the patient on tion score index (WMSI) was calculated by scoring each the morning of surgery using aseptic technique. This was segment (1 = normal, 2 = hypokinesis, 3 = akinesis, and allowed to clot before it was centrifuged at 3000 rpm 4 = dyskinesis) and dividing the total score by the numfor 10 min, after which the serum was recovered by asber of segments scored. WMSIs were obtained for the piration. Standard routine anesthesia was administered whole left ventricle (global WMSI), for the region conto all patients. Bone marrow (5-7 ml) was drawn from taining the infarcted areas (regional WMSI), and for the the sternum by standard technique prior to sternal split segments of infarction. To increase the specificity for using a standard bone marrow aspiration needle. The asthe diagnosis of transmural fibrosis, an infarcted area was pirated bone marrow was then mixed with the serum at defined as an akinetic or dyskinetic segment that does not a ratio of 1:2. Heparin was added to the mixture at a improve in contractility during low-dose dobutamine stress. final concentration of 50 U/ml. Samples of the mixture
The wall thickness for all infarcted segments was measured. were taken for an automated total nucleated cell count Left ventricular ejection fraction, end systolic and end diaas well as enumeration of CD34 + and CD117 + cells by stolic volumes, and the stroke volume were measured by 2D standard flow cytometric analysis. Intraoperative transechocardiography using the biplane method of disks; the esophageal echocardiography was performed in all the cardiac index was assessed by Doppler. patients to locate the infarcted area and quantify its thickness. The chest was opened through a median sterno-Monitoring of Cardiac Arrhythmia tomy and the infarcted area confirmed by direct vision.
Surveillance for heart rhythm disturbance included Core temperature was reduced to 32°C and short periods continuous ECG monitoring in the first postoperative of intermittent ischemia (12-18 min) interspersed with 24 h, a 12-lead ECG every day of the postoperative peshort periods of reperfusion (3 min) were used to conriod, and at 6 weeks and 10 months follow-up visit, and struct each of the coronary anastomoses. At the end of a 24-h Holter monitoring study when ambulant at 10 the revascularization procedure the diluted bone marrow months follow-up. was injected into the scarred area of the left ventricle Statistical Analysis with 250 µl/injection 1 cm apart into the mid-depth of the wall thickness. The inferior wall of the left ventricle Data are presented as mean ± SEM. Comparison between WMSI at baseline, 6 weeks, and 10 months was was the injected area in all the study patients and in performed by the repeated measures procedure using the 17 months. A mean of 2.2 ± 0.2 coronary artery anastomoses was constructed. Table 1 shows the operative SPSS package (IL). Interobserver agreement in wall motion scores was assessed by calculating the kappa coeffi-data. A mean of 26 ± 2 injections (range 16-44) of unma-cient where κ > 0.4, κ > 0.6, and κ > 0.8 represent a fair, good, and excellent agreement (7) ; 1923 out of the 2016 nipulated bone marrow was applied to the scarred left ventricular wall, causing an increase in wall thickness at (95%) of the LV segments were of sufficient quality for analysis. The interobserver agreement for the indepen-the site of injection from 0.74 ± 0.04 to 0.84 ± 0.04 cm (p < 0.05) measured by transesophageal echocardiogra-dent assessors for wall motion scoring was excellent (κ = 0.83). Student's t-test was used where appropriate. The phy. There were no immediate perioperative complications. The postoperative complications listed in Table 1 role of the number of nucleated and CD34 + /CD117 + cells injected in contractility changes was analyzed by multi-were not of a type that could attribute causation to the bone marrow injections. The mean stay of patients in ple regression analysis. The rationale for the measurement of CD34 + /CD117 + cells was based on the report by the hospital was 7.0 ± 0.6 days. There were no new electrocardiographic changes or significant elevation in cre-Orlic et al. (15) , where they selected hemopoietic precursors to treat mice with myocardial infarction (see be-atine kinase (475 ± 77 and 472 ± 31 IU/L at 6 and 24 h after the termination of surgery) or troponin T (1.5 ± 0.2 low). A value of p < 0.05 was taken as significant. and 0.8 ± 0.2 ng/ml at 6 and 24 h after the termination of RESULTS surgery) to indicate perioperative myocardial infarction. The clinical characteristics of the patients participat-There were no deaths, new myocardial infarctions, or other ing in the study are presented in Table 1 . All patients had cardiac events during the first 10 months of follow-up significant angina and dyspnea. All the patients were diand all patients improved clinically; the angina Canadian agnosed with triple vessel coronary artery disease and Cardiovascular Society class and dyspnea New York had impaired global left ventricular function. The mean Heart Association class mean values were reduced from period interval between the occurrence of myocardial in-3.0 ± 0.2 and 2.1 ± 0.2 before surgery to 1.1 ± 0.1 and farction and surgery for the study population was 23 ± 1.2 ± 0.1 at 6 weeks and to 0.3 ± 0.1 and 1.2 ± 0.1 at 10 months follow-up (p < 0.05 in both instances). A 24-h Holter performed at 10 months' follow-up did not show significant ventricular arrhythmias. These results dem- keeping with this, Figure 1a shows improvement in was obtained by biplane method of disks and contrasts with the left ventricular ejection fraction of 38 ± 2% areas under study may have contained both fibrotic tissue (i.e., akinetic) and viable myocardium (i.e., hypoki-measured by single plane left ventriculography). There was no significant difference in left ventricular ejection netic). The coexistence of fibrotic and viable myocardium in the regional analyses of contractile function is fraction at rest before and after surgery (44 ± 4% at 6 weeks and 48 ± 4% at 10 months); however, there was further supported by the biphasic response of the regional WMSI prior to surgery, improving from 2.32 to a significant improvement of the left ventricular ejection response to dobutamine stress following surgery (47 ± 2.06 at low-dose stress and deteriorating to 2.28 at peak stress. Interestingly, the deterioration of regional WMSI 2% before surgery vs. 58 ± 4% at 6 weeks and 55 ± 4% at 10 months at peak dose; p < 0.05). The end systolic seen before surgery was reversed at 6 weeks and 10 months after surgery. and end diastolic volumes and the stroke volume index at rest echocardiography were not significantly altered
The 34 infarcted segments in the 14 study patients were divided into three groups according to the treat-at any time period (57.0 ± 9.0 vs. 54.3 ± 8.7 and 55.9 ± 8.7 ml; 95.9 ± 9.5 vs. 87.0 ± 11.1 and 98.8 ± 10.7 ml; ment applied: (i) bone marrow injection alone (n = 11 segments), (ii) bypass graft alone (n = 13 segments), and 35.9 ± 1.5 vs. 32.0 ± 1.7 and 33.5 ± 1.2 ml/m 2 , respectively). On the other hand, the improvement in the car-(iii) bone marrow injection and bypass graft in combination (n = 10 segments). Figure 2 shows that, as expected, diac index seen with low and peak dobutamine stress prior to surgery (2.7 ± 0.2 vs. 4.0 ± 0.3 and 4.3 ± 0.3l/ the infarcted segments are predominantly akinetic, as the mean values for the segmental WMSI in the three min/m 2 ; p < 0.05) was also observed at 6 weeks (2.6 ± 0.2 vs. 4.0 ± 0.3 and 4.8 ± 0.2l/min/m 2 ; p < 0.05) and at groups were 3.0 ± 0.0, 3.0 ± 0.0, and 3.1 ± 0.1, respectively, and there was no contractile improvement with 10 months following surgery (2.6 ± 0.2 vs. 3.6 ± 0.3 and 4.5 ± 0. 3l/min/m 2 ; p < 0.05). dobutamine stress. Importantly, whereas bone marrow transplantation and bypass graft alone did not ameliorate To assess the impact of the bone marrow injections on regional function, we analyzed the wall motion score segmental WMSI, the combination of the two treatment modalities resulted in statistically significant improve-index in the ventricular walls containing injected infarct segments (regional WMSI). Figure 1b shows that the ment of the scores at low and peak dobutamine stress both at 6 weeks and 10 months after surgery, which may resting regional WMSI changed from 2.32 ± 0.12 before surgery to 2.35 ± 0.13 at 6 weeks and 2.07 ± 0.15 at 10 indicate an increase in contractile tissue in these segments. However, the improvement in contractility was months, a significant improvement (p < 0.05). However, the regional WMSIs of between 2 and 3 indicate that the not matched by a significant increase in wall thickness Figure 2 . Left ventricle (LV) segmental wall motion score index before surgery and 6 weeks and 10 months after surgery at rest and at low and peak dobutamine stress of infarcted segments that received injection of bone marrow alone (n = 11 segments), bypass graft alone (n = 13 segments), or bone marrow and bypass graft in combination (n = 10 segments). *p < 0.05 versus the corresponding mean values before surgery.
of all the infarcted segments (0.88 ± 0.04 and 0.86 ± The differentiation of bone marrow cells into myocytes, endothelial cells, and other tissue components necessary 0.04 cm at 6 weeks and at 10 months after surgery vs. 0.86 ± 0.04 cm before surgery; p = NS) and of the seg-to support the viability and function of the contractile units is probably the mechanism underlying the im-ments injected with bone marrow (0.92 ± 0.06 and 0.88 ± 0.05 cm at 6 weeks and at 10 months after surgery vs. provement of contractile function by bone marrow transplantation in our study. Indeed, it was shown as early as 0.86 ± 0.07 cm before surgery; p = NS) as measured by transthoracic echocardiography. Similarly, there was no 1968 that the bone marrow possessed pluripotential stem cells, which under appropriate experimental conditions correlation between the length of the period interval of myocardial infarctions and the segmental WMSI.
can differentiate into a broad spectrum of tissues (2). More recent experiments in animal preparations have shown The number of mononuclear cells and dual staining CD34 + /CD117 + (c-kit pos ) injected per each treated that bone marrow-derived progenitor cells are of enormous plasticity so that they can differentiate into myo-segment was 31.5 ± 3.5 × 10 6 and 0.61 ± 0.1 × 10 6 , respectively, and they were not correlated with the im-cardium (10,15,27), brain tissue (12) , liver (17), skeletal muscle (1), vessels (21), and other tissues. Human mes-provement in contractility. Previous studies have demonstrated that the putative pluripotential stem cell is enchymal stem cells were first isolated and shown to have multiple differentiation potential by Haynesworth Lin − c-kit pos in murine models of cardiac regeneration (15) . These cells exist at a low level within the bone et al. (4) . Thereafter, the multilineage potential of human mesenchymal cells was demonstrated by in vitro meth-marrow somewhere between 1 in 10,000 to 100,000 cells and it is reasonable to assume that only a relatively ods (18) and that these cells can differentiate into cardiomyocytes when injected in the left ventricle of the adult small number of true pluripotent stem cells has been transplanted at each injection site in our studies. murine heart (26) . Recently it has been suggested that bone marrow cells induce angiogenesis when injected DISCUSSSION into the infarct border zone in patients undergoing coro-The present study has demonstrated that transplantanary bypass grafting (28) and into the ischemic myocartion of unmanipulated autologous bone marrow into scar dium (23) . All the evidence suggests that bone marrow tissue of the human heart is safe and has shown for the is a potential inexhaustible source of pluripotential cells first time that it enhances cardiac function only when that can differentiate into a variety of cell types depenused in combination with myocardial revascularization. dent on local environmental cues. For ethical reasons and technical constraints, the possible differentiation of is considered. Moreover, direct injection of the bone marrow into the muscle may be an inefficient and impracti-bone marrow cells into vascular and contractile tissue was not investigated in the present study; however, our cal route of cell delivery and it is not known whether the intravascular and intracoronary administrations are finding that the improvement in contractility of the areas injected with bone marrow is only apparent when com-a better option. Recently it has been reported that the transendocardial transplantation of bone marrow cells is bined with bypass grafting suggests that the improvement on muscle contraction requires normalization of the safe in subjects with advanced coronary artery disease (3) and with chronic ischemic heart failure (16) and also blood supply. The results may imply that the transplantation of bone marrow cells into nonrevascularized myo-that the selective intracoronary transplantation of autologous mononuclear bone marrow cells is safe and effec-cardium lose the capacity to regenerate contractile structures or that they are not resilient to survive in a hypoxic tive in the context of acute (24) myocardial infarction. Despite the obvious importance of our results, it should environment.
The CD34 + /CD117 + counts are a simplistic analysis be emphasized that this was a nonrandomized study involving a small number of patients, and that the findings of possible stem cell number in the samples and will represent a significant overestimation of the true number should be confirmed in a larger randomized study. It is also worth noting that although the intramyocardial in-of pluripotent stem cells. Furthermore, the bone marrow taken and injected would contain a mixture of hemo-jection of autologous bone marrow is safe for the first 10 months following its application, longer follow-up poeitic stem cell (HSC), mesenchymal stem cells (MSC), and other undefined stem cells. Both HSC and MSC periods would be required to ascertain that the treatment does not induce long-term adverse events. have now been shown to have significant capacity to differentiate into a variety of cell types (1, 6,8,17, In conclusion, we have shown that transplantation of unmanipulated autologous bone marrow may provide a 19). However, it has been recently suggested that HSC transdifferentiation into nonhemopoietic cell lines is not novel and promising means of reversing postinfarction left ventricular dysfunction and may have important clini-common in the steady state (29) , although the response in the setting of selective tissue, whether this is normal cal implications for improving the long-term prognosis of these patients and possibly the prevention of the oc-or injured, is not known. While the debate over the specific capacity of HSCs to transdifferentiate remains un-currence of heart failure. The use of bone marrow avoids the complexity of cell culture techniques and the con-resolved, published data clearly suggest that marrowderived cells, whether distinct tissue specific or truly cerns that repeated in vitro passaging of primary cells like myoblasts may alter their ability to fuse and differ-pluripotent, can differentiate into a variety of cell types, a view supported by the clinical observation of this entiate (20). Furthermore, in comparison to transplanted allogenic and xenogenic cells, there is no risk of rejec-study. It is of interest that in the present study the total number of mononuclear cells or CD34 + /CD117 + cells in-tion or requirement for immunosuppressant drugs. jected was not correlated with the improvement in con-
